Viveve Medical Inc. (VIVE) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Viveve Medical Inc. (VIVE:NASDAQ), powered by AI.

Current Price
$0.00
P/E Ratio
-0.0
Market Cap
2,018
Sector
Healthcare
What is the Viveve Medical Inc. stock price forecast?

Viveve Medical Inc. is currently trading at $0.00. View real-time AI analysis on Alpha Lenz.

What is Viveve Medical Inc. insider trading activity?

View the latest insider trading data for Viveve Medical Inc. on Alpha Lenz.

What is Viveve Medical Inc.'s P/E ratio?

Viveve Medical Inc.'s P/E ratio is -0.0.

Viveve Medical Inc.

$0.00
NASDAQVIVE
Ask about Viveve Medical Inc.'s future dividend policy...
Alpha Chat Insight

Viveve Medical Inc. trades at a P/E of -0.0 (undervalued) with modest ROE of -202.2%.

Ask for details

Company Overview

Viveve Medical Inc. specializes in the design, development, manufacturing, and marketing of medical devices primarily focused on women's health. Its flagship product, the Viveve System, employs Cryogen-cooled Monopolar Radiofrequency technology for non-invasive treatments addressing vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. This innovative medical technology plays a significant role in enhancing women's well-being by offering low-risk, high-reward procedures. Viveve Medical Inc. operates across a global network, including the Americas, Europe, and Asia-Pacific regions, making it a notable player in the healthcare sector, particularly within the medical devices industry.

CEOMs. Deborah Ann Jorn M.B.A.
SectorHealthcare
IndustryMedical Devices
Employees47

Company Statistics

(FY 2021)

Profile

Market Cap$2.02K
Revenue$6.43M
Shares Out0.00
Employees47

Margins

Gross9.65%
EBITDA-320.84%
Operating-335.40%
Pre-Tax-338.80%
Net-342.78%

Valuation

P/E-0.00
P/B0.00
EV/Sales0.00
EV/EBITDA0.67
P/FCF-0.00

Growth (CAGR)

Rev 3Yr-29.73%
Rev 5Yr-2.09%
Op Inc 3YrN/A
Op Inc 5YrN/A
Net Inc 3YrN/A
Net Inc 5YrN/A

Returns

ROA-103.55%
ROE-202.21%
ROIC-97.65%

Financial Health

Cash & Cash Equivalents$19.16M
Net Debt$-8.31M
Debt/Equity72.00%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Viveve Medical Inc. (Healthcare) Stock Forecast & Analysis $0.00 | Alpha Lenz